XML 47 R40.htm IDEA: XBRL DOCUMENT v2.4.0.8
Merger with XenneX, Inc (Tables) (Merger with XenneX, Inc. [Member])
 12 Months Ended
Dec. 31, 2013
Merger with XenneX, Inc. [Member]
  
Business Acquisition [Line Items]  
Components and Allocation of Purchase Price

Components of the purchase price:
 
 
BioTime common shares
 
$
1,802,684
 
LifeMap Sciences common shares
  
2,501,415
 
Total purchase price
 
$
4,304,099
 
 
    
Preliminary allocation of purchase price:
    
Assets acquired and liabilities assumed:
    
Cash
 
$
292,387
 
Other current assets
  
311,118
 
Intangible assets
  
4,273,420
 
Current liabilities
  
(294,572
)
Cash distributable to sellers
  
(278,254
)
Net assets acquired
 
$
4,304,099